This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Metabolic Syndrome
and you are
between 45 and 70
years old
The phase for this study is not defined.
Show me locations

The purpose

The primary objective is to evaluate the efficacy of FaseMETS for 6 consecutive months in lowering serum lipids and glucose in subjects with Metabolic Syndrome; The secondary objectives of the trial are: - to evaluate the potential benefit after 3 months of therapy (by an interim analysis) - to evaluate the safety of FaseMETS

Provided treatments

  • : Daily administration: 2 tablets FaseMETS a day

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02912325. The sponsor of the trial is MDM S.p.A. and it is looking for 34 volunteers for the current phase.
Official trial title:
A Pilot, Non-Comparative Study to Assess the Efficacy and Safety of the New Food Supplement FaseMETS in Metabolic Syndrome